Newport Beach, CA, United States of America

Adriana Garcia

This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adriana Garcia. Retrieved from https://idiyas.com/inventor/adriana-garcia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Adriana Garcia: Advancing Diabetes Research through Innovative Imaging

Adriana Garcia, an inventive mind based in Newport Beach, California, has made significant strides in the realm of medical innovations. With one patented invention to her name, Garcia is paving the way for advancements in diabetes research.

Latest Patents

Garcia's notable patent is titled "Imaging agents for monitoring changes of dopamine receptors and methods of using thereof." This groundbreaking invention offers a method for screening subjects to assess their likelihood of developing diabetes by quantifying insulin-producing cells. Furthermore, it serves to improve the diagnosis of diabetes and facilitates monitoring disease progression or the efficacy of candidate drugs.

Career Highlights

Garcia's work is conducted at the esteemed University of California. Her contributions to the field of diabetes research through her innovative patent underscore her commitment to improving healthcare outcomes.

Collaborations

Throughout her career, Garcia has collaborated with esteemed colleagues such as Jogeshwar Mukherjee and George Chandy. These collaborations enhance the interdisciplinary approach to her research, allowing for richer insights and innovations within the field.

Conclusion

Adriana Garcia is a pivotal figure in the intersection of medical imaging and diabetes research. Her innovative patented methods not only bolster the understanding of diabetes but also open new pathways for effective treatments. As she continues her work at the University of California, the potential for future innovations remains promising.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…